{
    "title": "109_hr2959",
    "content": "Parkinson's Disease Research, Education, and Clinical Centers. The Secretary will designate six Department health-care facilities as Parkinson's Disease research, education, and clinical centers, subject to sufficient funds. The Secretary will designate Department health-care facilities as Parkinson's Disease research, education, and clinical centers, ensuring appropriate geographic distribution and effectiveness in carrying out established purposes. The Secretary may not designate a facility unless approved by a peer review panel. The Secretary will designate Department health-care facilities as Parkinson's Disease research, education, and clinical centers based on competitive scientific and clinical merit. The facility must have arrangements with accredited medical schools for innovative education and training in neurology, attract capable scientists for health-care research efforts. The Secretary designates health-care facilities as Parkinson's Disease research, education, and clinical centers based on scientific and clinical merit. These centers must have advisory committees, evaluation capabilities, and the ability to coordinate national education, clinical, and research activities for neurodegenerative diseases like Parkinson's Disease. The Under Secretary for Health establishes a panel to assess proposals for new centers focused on neurodegenerative diseases, including Parkinson's Disease and other movement disorders. The panel consists of experts in these fields. The panel, consisting of experts in neurodegenerative diseases, including Parkinson's Disease and other movement disorders, will review proposals submitted by the Under Secretary for Health and provide their views on the scientific and clinical merit of each proposal. Panel members will serve as consultants for a maximum of two years, with half appointed for three years and half for two years to ensure continuity. The panel is not subject to the Federal Advisory Committee Act. Before funding a center at a non-designated health-care facility, the Secretary must ensure its operation meets certain criteria. The Secretary must ensure adequate funding for Parkinson's Disease research, education, and clinical activities at designated facilities. Appropriations are authorized for research and education activities at established centers. Clinical and scientific investigations at these centers are eligible for funding from Department appropriations. The Secretary must ensure adequate funding for Parkinson's Disease research, education, and clinical activities at designated facilities. Appropriations are authorized for research and education activities at established centers, with priority given to projects related to Parkinson's disease and other movement disorders. Section 7329 of title 38, United States Code, regarding Parkinson's disease research, education, and clinical centers, will be effective on October 1, 2005."
}